Published in Arthritis Res Ther on November 04, 2013
An update on the genetic architecture of hyperuricemia and gout. Arthritis Res Ther (2015) 0.87
Association of SLC2A9 genotype with phenotypic variability of serum urate in pre-menopausal women. Front Genet (2015) 0.81
Common Variants in LRP2 and COMT Genes Affect the Susceptibility of Gout in a Chinese Population. PLoS One (2015) 0.77
GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes. Ann Rheum Dis (2016) 0.76
Positive association of tomato consumption with serum urate: support for tomato consumption as an anecdotal trigger of gout flares. BMC Musculoskelet Disord (2015) 0.76
Serum urate gene associations with incident gout, measured in the Framingham Heart Study, are modified by renal disease and not by body mass index. Rheumatol Int (2015) 0.75
The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets. PLoS One (2016) 0.75
Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum (1977) 8.55
Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet (2010) 4.36
Alcohol intake and risk of incident gout in men: a prospective study. Lancet (2004) 4.12
Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ (2008) 3.71
Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol (2002) 3.13
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04
Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum (2008) 2.91
Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum (2004) 1.51
A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets. Hum Mol Genet (2010) 1.33
Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets. Arthritis Rheum (2009) 1.32
Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Ann Rheum Dis (2010) 1.31
Relation of serum uric acid to body bulk, haemoglobin, and alcohol intake in two South Pacific Polynesian populations. Ann Rheum Dis (1968) 1.20
The renal urate transporter SLC17A1 locus: confirmation of association with gout. Arthritis Res Ther (2012) 1.08
Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout. Ann Rheum Dis (2013) 1.04
Megalin and nonmuscle myosin heavy chain IIA interact with the adaptor protein Disabled-2 in proximal tubule cells. Kidney Int (2009) 0.99
Megalin/LRP2 expression is induced by peroxisome proliferator-activated receptor -alpha and -gamma: implications for PPARs' roles in renal function. PLoS One (2011) 0.96
Population heterogeneity in the genetic control of serum urate. Semin Nephrol (2011) 0.95
Effect of genetic polymorphisms on development of gout. J Rheumatol (2013) 0.90
Significant interaction between LRP2 rs2544390 in intron 1 and alcohol drinking for serum uric acid levels among a Japanese population. Gene (2012) 0.88
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) (2012) 5.22
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet (2003) 4.84
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07
Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry (2002) 4.03
Why psychiatry can't afford to be neurophobic. Br J Psychiatry (2009) 3.80
Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry (2006) 3.35
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) (2012) 2.83
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med (2006) 2.79
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull (2006) 2.71
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ (2012) 2.70
Outcomes of conduct problems in adolescence: 40 year follow-up of national cohort. BMJ (2009) 2.47
Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs. Br J Psychiatry (2012) 2.41
Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practice. N Z Med J (2012) 2.37
Disease-relevant autoantibodies in first episode schizophrenia. J Neurol (2010) 2.33
Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One (2012) 2.33
Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction (2007) 2.20
Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry (2013) 2.17
Association of higher DEFB4 genomic copy number with Crohn's disease. Am J Gastroenterol (2009) 2.14
Schizophrenia in the offspring of antenatally depressed mothers in the northern Finland 1966 birth cohort: relationship to family history of psychosis. Am J Psychiatry (2009) 2.11
A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res (2011) 2.09
Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study. Br J Psychiatry (2011) 2.06
Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis. Arthritis Rheum (2008) 1.99
Raised incidence rates of all psychoses among migrant groups: findings from the East London first episode psychosis study. Arch Gen Psychiatry (2008) 1.96
Reliability and comparability of psychosis patients' retrospective reports of childhood abuse. Schizophr Bull (2009) 1.94
A delphi exercise to identify characteristic features of gout - opinions from patients and physicians, the first stage in developing new classification criteria. J Rheumatol (2013) 1.77
Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology (2005) 1.76
Self-harm in first-episode psychosis. Br J Psychiatry (2008) 1.72
Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry (2007) 1.71
TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort. J Gastroenterol Hepatol (2007) 1.70
Infant developmental milestones and subsequent cognitive function. Ann Neurol (2007) 1.69
Developmental typology of trajectories to nighttime bladder control: epidemiologic application of longitudinal latent class analysis. Am J Epidemiol (2003) 1.65
A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation. PLoS Med (2010) 1.60
Childhood cognitive ability and adult mental health in the British 1946 birth cohort. Soc Sci Med (2007) 1.54
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum (2012) 1.54
Forty-year psychiatric outcomes following assessment for internalizing disorder in adolescence. Am J Psychiatry (2007) 1.54
Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry (2008) 1.53
The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease. Respirology (2012) 1.49
Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort. Arthritis Rheum (2005) 1.48
A longitudinal typology of symptoms of depression and anxiety over the life course. Biol Psychiatry (2007) 1.47
Childhood infection and adult schizophrenia: a meta-analysis of population-based studies. Schizophr Res (2012) 1.46
Efficacy and tolerability of probenecid as urate-lowering therapy in gout; clinical experience in high-prevalence population. J Rheumatol (2013) 1.45
Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England. Am J Psychiatry (2005) 1.42
Cannabis use and outcome of recent onset psychosis. Eur Psychiatry (2005) 1.42
Recovery from schizophrenic psychoses within the northern Finland 1966 Birth Cohort. J Clin Psychiatry (2005) 1.42
Neighbourhood-level effects on psychoses: re-examining the role of context. Psychol Med (2007) 1.38
Cohort profile: risk patterns and processes for psychopathology emerging during adolescence: the ROOTS project. Int J Epidemiol (2009) 1.37
The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain (2003) 1.35
Functional expression and characterization of Schistosoma mansoni cathepsin B and its trans-activation by an endogenous asparaginyl endopeptidase. Mol Biochem Parasitol (2003) 1.34
Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand. Rheumatology (Oxford) (2009) 1.34
A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets. Hum Mol Genet (2010) 1.33
Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets. Arthritis Rheum (2009) 1.32
IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. Am J Gastroenterol (2007) 1.32
Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology (2005) 1.32
Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Ann Rheum Dis (2010) 1.31
Gender differences in the association between childhood abuse and psychosis. Br J Psychiatry (2009) 1.30
National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology (Oxford) (2012) 1.30
The gouty tophus: a review. Curr Rheumatol Rep (2015) 1.26
Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis. JAMA Psychiatry (2013) 1.25
Outcome domains for studies of acute and chronic gout. J Rheumatol (2009) 1.24
Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc Natl Acad Sci U S A (2002) 1.22
Cercarial elastase is encoded by a functionally conserved gene family across multiple species of schistosomes. J Biol Chem (2002) 1.22
Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children. Am J Psychiatry (2007) 1.20
The genetic basis of hyperuricaemia and gout. Joint Bone Spine (2010) 1.20
Genetic progress towards the molecular basis of autoimmunity. Trends Mol Med (2006) 1.20
Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations. Am J Psychiatry (2009) 1.20
The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. Arthritis Rheum (2011) 1.18
Social deprivation, inequality, and the neighborhood-level incidence of psychotic syndromes in East London. Schizophr Bull (2012) 1.17
Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort. Soc Psychiatry Psychiatr Epidemiol (2003) 1.16
Profiles of family-focused adverse experiences through childhood and early adolescence: the ROOTS project a community investigation of adolescent mental health. BMC Psychiatry (2011) 1.15
Predictors of schizophrenia--a review. Br Med Bull (2005) 1.15
Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab (2007) 1.13
Mokken scale analysis of mental health and well-being questionnaire item responses: a non-parametric IRT method in empirical research for applied health researchers. BMC Med Res Methodol (2012) 1.11
A sequence variant associated with sortilin-1 (SORT1) on 1p13.3 is independently associated with abdominal aortic aneurysm. Hum Mol Genet (2013) 1.10
Developing a provisional definition of flare in patients with established gout. Arthritis Rheum (2012) 1.10
Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol (2011) 1.10
Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load. Ann Rheum Dis (2013) 1.08
Visuospatial learning and executive function are independently impaired in first-episode psychosis. Psychol Med (2005) 1.08